Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | US | 2023

The global COVID-19 pandemic has had a negative impact on the IC device market to some extent. The US IC device market is mature and facing intense pricing pressure on established products, limiting the overall market growth and leading to a slight decline. However, several new technologies are poised to enter the IC device space that could improve patient care and outcomes. These products are also expected to support premium prices, which could change the existing treatment algorithms, disrupting the established category leaders.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in the US, with market projections from 2019 through 2031.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Interventional Cardiology Devices – Market Insights – Middle East (Supplemental)
The MESA IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive…
Report
Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2025
The Latin American IC device market has recovered from the COVID-19 pandemic and is reverting to prepandemic growth trends. Increasing patient pool, launch of newer generation devices and…
Report
Interventional Cardiology Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally…